Crossmark

Complement in neurological disorders and emerging complement-targeted therapeutics

Crossref DOI link: https://doi.org/10.1038/s41582-020-0400-0

Published Online: 2020-10-01

Published Print: 2020-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dalakas, Marinos C. https://orcid.org/0000-0001-7070-1134
Alexopoulos, Harry

Spaeth, Peter J. https://orcid.org/0000-0003-4891-2466
License Information

Text and Data Mining valid from 2020-10-01

Version of Record valid from 2020-10-01
More Information

Article History

Accepted: 7 August 2020

First Online: 1 October 2020

Competing interests

: The authors declare no competing interests.